
Loading, please wait...

Loading, please wait...

Modern drug discovery is shifting from the "one drug, one target" model to a more complex understanding of multi-target interactions. Specifically, the PPB3 target prediction tool has emerged as a powerful web-based solution for assessing polypharmacology. By identifying how drug-like molecules interact with multiple biological targets, researchers can better predict both therapeutic potential and unintended side effects.
Furthermore, the PPB3 model utilizes deep neural networks trained on the extensive ChEMBL 34 database. This dataset includes over 1.1 million molecules and roughly 2.5 million interactions. Consequently, the tool covers 7,546 targets, including cell lines and organisms, which were often excluded from previous versions. Therefore, this expanded scope provides a much more comprehensive view of molecular bioactivity than older protein-only models.
Specifically, the tool excels in precision and recall when identifying targets where a molecule is significantly active. Additionally, users can perform these predictions online, making high-level bioinformatics accessible to a broader scientific community. Moreover, understanding these interactions is crucial for drug repurposing efforts in India and globally. Consequently, this technology helps clinicians and researchers identify new uses for existing drugs while minimizing toxicity risks. However, users should always validate computational predictions with experimental data.
The PPB3 tool uses deep learning to predict the biological targets of small molecules, helping researchers understand polypharmacology profiles and potential side effects.
The current version uses ChEMBL 34, containing a much larger dataset of over 7,500 targets, including cell lines and protein complexes, compared to older models limited to single proteins.
Disclaimer: This content is for informational and educational purposes only. It is not intended as medical advice or as a substitute for professional healthcare. Always seek the advice of a qualified health provider regarding any medical condition. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Researchers developed PPB3, a deep learning tool for target prediction and polypharmacology assessment, utilizing a vast dataset of 7,546 targets....
8 months ago

As monsoon seasons elevate arboviral disease threats, Tamil Nadu has initiated an ICMR-monitored evaluation of the tetravalent dengue vaccine in Tenkasi district. Clinicians emphasize clinical monitoring, public prevention, and high-quality early pediatric care to reduce disease morbidity across endemic regions.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today